What one share of Intellia Therapeutics holds
Intellia Therapeutics, Inc. (“we,” “us,” “our,” “Intellia,” or the “Company”) is a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core technologies. Our mission is to transform the lives of people with severe diseases by developing and commercializing potentially curative treatments.
Intellia Therapeutics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.50 |
|---|---|
| Profit | −$3.35 |
| Capex (buildings and equipment) | $0.02 |
| Free cash flow | −$2.92 |
| Cash and investments | $4.49 |
| Book value | $5.20 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2015 | — | −$51.02 | $10.51 | −$17.77 | — | — |
| 2016 | $0.74 | −$1.42 | $0.28 | $1.35 | — | $5.83 |
| 2017 | $0.73 | −$1.88 | $0.28 | −$2.09 | — | $7.09 |
| 2018 | $0.71 | −$1.98 | $0.15 | −$1.57 | — | $6.15 |
| 2020 | $1.04 | −$2.40 | $0.06 | −$0.96 | — | $7.96 |
| 2021 | $0.47 | −$3.78 | $0.18 | −$3.35 | — | $13.97 |
| 2022 | $0.68 | −$6.16 | $0.18 | −$4.51 | — | $14.19 |
| 2023 | $0.41 | −$5.42 | $0.16 | −$4.60 | — | $11.29 |
| 2024 | $0.59 | −$5.25 | $0.06 | −$3.59 | — | $8.55 |
| 2025 | $0.62 | −$3.81 | $0.01 | −$3.65 | — | $5.77 |
Common questions about Intellia Therapeutics
How much does one share of Intellia Therapeutics earn?
Over the last 12 months, Intellia Therapeutics lost $3.35 for each share on $0.50 of sales.
Does Intellia Therapeutics pay a dividend?
Intellia Therapeutics didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Intellia Therapeutics’s book value per share?
Intellia Therapeutics’s book value is $5.20 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Intellia Therapeutics have?
Each share of Intellia Therapeutics has $4.49 of cash and investments, as of June 30, 2026.
What is Intellia Therapeutics’s free cash flow per share?
−$2.92 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Intellia Therapeutics bought back shares?
Intellia Therapeutics’s share count rose about 44499% from 2015 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.